Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 619 results for "sandoz inc"

Upsher-Smith sells AmLactin to Sandoz

MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. has entered an agreement to sell its AmLactin skin care brand to Sandoz Inc. Financial terms of the deal weren't disclosed. Upsher-Smith said the move is part of its strategy of focusing on ... Chain Drug Review, 1 month ago
Upsher-Smith Divests AmLactin® Brand Family TickerTech.com, 1 month ago
Upsher-Smith divests AmLactin brands Mass Market Retailers, 1 month ago
[x]  

Sandoz releases generic version of Latisse

PRINCETON, N.J. — Sandoz Inc. has introduced bimatoprost ophthalmic solution 0.03%, an eyelash treatment, in the U.S. market. The Novartis subsidiary said its bimatoprost ophthalmic product is a generic version of Latisse from Allergan. A ...
 Chain Drug Review1 month ago Sandoz Launches Generic Version Of Emend Capsules  BioSpace2 weeks ago

Amgen v. Sandoz: SCOTUS to Solve the Riddle Wrapped in a Mystery Inside an Enigma

Last week, the United States Supreme Court granted certiorari review of the Amgen v. Sandoz decision. Amgen Inc. v. Sandoz Inc., 794 F.3d 1347, 1351 (Fed. Cir. 2015), cert. granted, (U.S. Jan. 13, 2017). In Amgen v. Sandoz, the Federal Circuit ...
 JD Supra3 days ago Breaking News: Supreme Court Grants Petition and Cross-Petition for Certiorari in Amgen v. Sandoz  JD Supra5 days ago Supreme Court to Consider Biologics Price Competition and Innovation Act  JD Supra2 days ago Confidentiality in BPCIA Cases  JD Supra2 weeks ago

Solicitor General Sides With Sandoz On Interpretation Of Biosimilar Statute

The Solicitor General of the United States has filed an amicus brief in Sandoz Inc. v. Amgen Inc . , asking the Supreme Court to grant certiorari and reverse the Federal Circuit's interpretation of one of the patent dance provisions of the ...
 National Law Review1 month ago Biosimilars: Solicitor General Recommends Granting Certiorari in Amgen v. Sandoz  JD Supra1 month ago PREMIER : Statement on Biosimilar Legal Challenge  4 Traders1 month ago
InvestorPlace.com

Why the Amgen, Inc. (AMGN) Patent Case Is So Important

Good news for Amgen, Inc. (NASDAQ:AMGN) shareholders … or, maybe it's bad news for anyone who owns AMGN stock. Whatever the case, the nation's judicial system is finally going to make legal sense of how the industry is supposed to make and market ...
 InvestorPlace.com3 days ago Amgen - More Willingness To Pay  Seeking Alpha1 month ago Amgen's Competition Against Its Top Products: A Comprehensive Look For 2017-2018  Seeking Alpha1 month ago

Apricus Biosciences Announces Approval of Vitaros ® for the Treatment of Erectile Dysfunction in Mexico

SAN DIEGO, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Mexico has granted Apricus commercialization partner, ...
 Stockwatch3 days ago Apricus Biosciences Release: Biotech Announces Approval Of Vitaros For The Treatment Of Erectile Dysfunction In Mexico  BioSpace3 days ago
[x]  

Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira1 (adalimumab)

Release date- 05012017 - Pfizer Inc. (NYSE:PFE) today announced that the comparative, confirmatory REFLECTIONS B538-02 study met its primary objective by demonstrating equivalent efficacy as measured by the American College of Rheumatology 20 ...
 Pharmacy Choice2 weeks ago PFIZER : Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira1 (adalimumab)  4 Traders2 weeks ago
[x]  

NOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs

By Brent Kendall WASHINGTON -- The Supreme Court on Friday agreed to consider a dispute between Novartis AG and Amgen Inc. that could determine how soon cheaper, copycat versions of biotechnology drugs can be sold to consumers. At issue is whether a ...
 4 Traders1 week ago Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs  Morningstar.com1 week ago

Blog Coverage Novartis Joins Hands with Ionis Pharma For Cardiovascular Treatment Solutions

/Active Wall St. blog coverage looks at the headline from Novartis AG (NYSE:NVS) and Ionis Pharmaceuticals Inc. (NASDAQ:IONS). Novartis announced on January 06, 2017, a collaboration and option agreement, with Ionis Pharma and its affiliate Akcea ...
 Nasdaq1 week ago NOVARTIS AG : Blog Coverage Novartis Joins Hands with Ionis Pharma For Cardiovascular Treatment Solutions  4 Traders1 week ago
[x]  
Zacks.com

Momenta (MNTA) to Receive $50M Under CSL Collaboration

Momenta Pharmaceuticals, Inc. MNTA announced that it has entered into an exclusive research collaboration and worldwide license agreement with CSL Limited. Momenta's share price has outperformed the Zacks classified Medical Biomed/Genetics in ...
 Zacks.com2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less